Literature DB >> 2495965

Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors.

U Simeoni1, J Messer, P Weisburd, J Haddad, D Willard.   

Abstract

Three cases of renal dysfunction at birth were observed in premature babies exposed in utero to prostaglandin synthetase inhibitors (PSI) and corticosteroids. Transient water and sodium retention with uraemia occurred in one patient, and severe acute renal failure with marked hyperkalaemia in twins. These findings may be due to impairment of prostaglandin (PG)-mediated renal adaptation to stress conditions after transplacental passage of PSI. Corticosteroids may also have affected PG synthesis inhibition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495965     DOI: 10.1007/bf00444137

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Intrauterine exposure to indomethacin.

Authors:  A J vd Heijden; D Tibboel; W P Fetter; E D Wolff
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

2.  Congestive heart failure from suspected ductal closure in utero.

Authors:  R A Arcilla; O G Thilenius; K Ranniger
Journal:  J Pediatr       Date:  1969-07       Impact factor: 4.406

3.  Naproxen levels in preterm infants after maternal treatment.

Authors:  A R Wilkinson
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321

Review 4.  Participation of renal cortical prostaglandins in the regulation of glomerular filtration rate.

Authors:  J Schnermann; J P Briggs
Journal:  Kidney Int       Date:  1981-06       Impact factor: 10.612

5.  [Prostaglandins and thromboxanes. Current viewpoint].

Authors:  G Béréziat
Journal:  Rev Prat       Date:  1981-10-11

6.  The disposition of indomethacin in preterm babies.

Authors:  S J Yaffe; W F Friedman; D Rogers; P Lang; M Ragni; C Saccar
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

7.  [Trans-placental transfer of four anti-inflammatory agents. A study carried out by in vitro perfusion (author's transl)].

Authors:  R Akbaraly; J J Leng; A Brachet-Liermain; P White; B Laclau-Lacrouts
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1981

8.  Further study of the inhibition of premature labor by indomethacin. Part I.

Authors:  H Zuckerman; E Shalev; G Gilad; E Katzuni
Journal:  J Perinat Med       Date:  1984       Impact factor: 1.901

9.  Disposition of indomethacin in preterm infants.

Authors:  R Bhat; D Vidyasagar; M Vadapalli; C Whalley; E Fisher; A Hastreiter; M Evans
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

10.  Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors.

Authors:  B Cantor; T Tyler; R M Nelson; G H Stein
Journal:  J Reprod Med       Date:  1980-05       Impact factor: 0.142

View more
  7 in total

Review 1.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  NSAID-induced nephrotoxicity from the fetus to the child.

Authors:  L Cuzzolin; M Dal Cerè; V Fanos
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

Review 3.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

4.  Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents.

Authors:  B S Kaplan; I Restaino; D S Raval; R P Gottlieb; J Bernstein
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

Review 5.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam.

Authors:  L E Voyer; R Drut; J H Méndez
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 7.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.